+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Bioprocess Validation Market Research Report by Test Type, Process Component, End User, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 127 Pages
  • October 2022
  • Region: United States
  • 360iResearch™
  • ID: 5121969
UP TO OFF until Dec 31st 2022
The United States Bioprocess Validation Market size was estimated at USD 61.30 million in 2021, USD 73.80 million in 2022, and is projected to grow at a CAGR of 16.62% to reach USD 154.23 million by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Bioprocess Validation to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Test Type, the market was studied across Compatibility Testing Services, Extractables/Leachables Testing Services, Integrity Testing Services, and Microbiological Testing Services.
  • Based on Process Component, the market was studied across Bioreactors, Filter Elements, Freezing and Thawing Process Bags, Media Containers and Bags, Mixing Systems, and Transfer Systems.
  • Based on End User, the market was studied across Biotechnology Companies, Contract Development & Manufacturing Organizations, and Pharmaceutical Companies.
  • Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. This ongoing research amplifies This research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

The publisher continuously monitors and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Bioprocess Validation market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Bioprocess Validation Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Bioprocess Validation Market, including Almac Group, BiOZEEN, Cobetter Filtration Equipment Co., Ltd., Doc S.r.l, Eurofins Scientific, Hangzhou Anow Microfiltration Co., Ltd., Meissner Filtration Products, Inc., Merck KGaA, Pall Corporation, Porvair plc, Sartorius Stedim Biotech S.A., SGS S.A., Thermo Fisher Scientific, Inc, Tianshan Precision Filter Material Co., Ltd., and Toxikon Corporation.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Bioprocess Validation Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Bioprocess Validation Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Bioprocess Validation Market?
4. What is the competitive strategic window for opportunities in the United States Bioprocess Validation Market?
5. What are the technology trends and regulatory frameworks in the United States Bioprocess Validation Market?
6. What is the market share of the leading vendors in the United States Bioprocess Validation Market?
7. What modes and strategic moves are considered suitable for entering the United States Bioprocess Validation Market?
Frequently Asked Questions about the U.S. Bioprocess Validation Market

What is the estimated value of the U.S. Bioprocess Validation Market?

The U.S. Bioprocess Validation Market was estimated to be valued at $61.3 Million in 2021.

What is the growth rate of the U.S. Bioprocess Validation Market?

The growth rate of the U.S. Bioprocess Validation Market is 16.6%, with an estimated value of $154.23 Million by 2027.

What is the forecasted size of the U.S. Bioprocess Validation Market?

The U.S. Bioprocess Validation Market is estimated to be worth $154.23 Million by 2027.

Who are the key companies in the U.S. Bioprocess Validation Market?

Key companies in the U.S. Bioprocess Validation Market include Almac Group, BiOZEEN, Cobetter Filtration Equipment Co., Ltd., Doc S.r.l, Eurofins Scientific, Hangzhou Anow Microfiltration Co., Ltd., Meissner Filtration Products, Inc., Merck KGaA and Porvair plc.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
6. Bioprocess Validation Market, by Test Type
6.1. Introduction
6.2. Compatibility Testing Services
6.3. Extractables/Leachables Testing Services
6.4. Integrity Testing Services
6.5. Microbiological Testing Services
7. Bioprocess Validation Market, by Process Component
7.1. Introduction
7.2. Bioreactors
7.3. Filter Elements
7.4. Freezing and Thawing Process Bags
7.5. Media Containers and Bags
7.6. Mixing Systems
7.7. Transfer Systems
8. Bioprocess Validation Market, by End User
8.1. Introduction
8.2. Biotechnology Companies
8.3. Contract Development & Manufacturing Organizations
8.4. Pharmaceutical Companies
9. California Bioprocess Validation Market
9.1. Introduction
10. Florida Bioprocess Validation Market
10.1. Introduction
11. Illinois Bioprocess Validation Market
11.1. Introduction
12. New York Bioprocess Validation Market
12.1. Introduction
13. Ohio Bioprocess Validation Market
13.1. Introduction
14. Pennsylvania Bioprocess Validation Market
14.1. Introduction
15. Texas Bioprocess Validation Market
15.1. Introduction
16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis, By Key Player
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion
17. Company Usability Profiles
17.1. Almac Group
17.1.1. Business Overview
17.1.2. Key Executives
17.1.3. Product & Services
17.2. BiOZEEN
17.2.1. Business Overview
17.2.2. Key Executives
17.2.3. Product & Services
17.3. Cobetter Filtration Equipment Co., Ltd.
17.3.1. Business Overview
17.3.2. Key Executives
17.3.3. Product & Services
17.4. Doc S.r.l
17.4.1. Business Overview
17.4.2. Key Executives
17.4.3. Product & Services
17.5. Eurofins Scientific
17.5.1. Business Overview
17.5.2. Key Executives
17.5.3. Product & Services
17.6. Hangzhou Anow Microfiltration Co., Ltd.
17.6.1. Business Overview
17.6.2. Key Executives
17.6.3. Product & Services
17.7. Meissner Filtration Products, Inc.
17.7.1. Business Overview
17.7.2. Key Executives
17.7.3. Product & Services
17.8. Merck KGaA
17.8.1. Business Overview
17.8.2. Key Executives
17.8.3. Product & Services
17.9. Pall Corporation
17.9.1. Business Overview
17.9.2. Key Executives
17.9.3. Product & Services
17.10. Porvair plc
17.10.1. Business Overview
17.10.2. Key Executives
17.10.3. Product & Services
17.11. Sartorius Stedim Biotech S.A.
17.11.1. Business Overview
17.11.2. Key Executives
17.11.3. Product & Services
17.12. SGS S.A.
17.12.1. Business Overview
17.12.2. Key Executives
17.12.3. Product & Services
17.13. Thermo Fisher Scientific, Inc
17.13.1. Business Overview
17.13.2. Key Executives
17.13.3. Product & Services
17.14. Tianshan Precision Filter Material Co., Ltd.
17.14.1. Business Overview
17.14.2. Key Executives
17.14.3. Product & Services
17.15. Toxikon Corporation
17.15.1. Business Overview
17.15.2. Key Executives
17.15.3. Product & Services
18. Appendix
18.1. Discussion Guide
18.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES BIOPROCESS VALIDATION MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, 2021 VS 2027
FIGURE 3. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 4. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 5. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 6. UNITED STATES BIOPROCESS VALIDATION MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 7. UNITED STATES BIOPROCESS VALIDATION MARKET DYNAMICS
FIGURE 8. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2021 VS 2027 (%)
FIGURE 9. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 10. UNITED STATES BIOPROCESS VALIDATION MARKET COMPETITIVE STRATEGIC WINDOW, BY TEST TYPE, 2027
FIGURE 11. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY COMPATIBILITY TESTING SERVICES, 2018-2027 (USD MILLION)
FIGURE 12. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY EXTRACTABLES/LEACHABLES TESTING SERVICES, 2018-2027 (USD MILLION)
FIGURE 13. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY INTEGRITY TESTING SERVICES, 2018-2027 (USD MILLION)
FIGURE 14. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY MICROBIOLOGICAL TESTING SERVICES, 2018-2027 (USD MILLION)
FIGURE 15. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2021 VS 2027 (%)
FIGURE 16. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2021 VS 2027 (USD MILLION)
FIGURE 17. UNITED STATES BIOPROCESS VALIDATION MARKET COMPETITIVE STRATEGIC WINDOW, BY PROCESS COMPONENT, 2027
FIGURE 18. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY BIOREACTORS, 2018-2027 (USD MILLION)
FIGURE 19. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY FILTER ELEMENTS, 2018-2027 (USD MILLION)
FIGURE 20. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY FREEZING AND THAWING PROCESS BAGS, 2018-2027 (USD MILLION)
FIGURE 21. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY MEDIA CONTAINERS AND BAGS, 2018-2027 (USD MILLION)
FIGURE 22. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY MIXING SYSTEMS, 2018-2027 (USD MILLION)
FIGURE 23. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY TRANSFER SYSTEMS, 2018-2027 (USD MILLION)
FIGURE 24. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 25. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2021 VS 2027 (USD MILLION)
FIGURE 26. UNITED STATES BIOPROCESS VALIDATION MARKET COMPETITIVE STRATEGIC WINDOW, BY END USER, 2027
FIGURE 27. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2027 (USD MILLION)
FIGURE 28. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, 2018-2027 (USD MILLION)
FIGURE 29. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2027 (USD MILLION)
FIGURE 30. CALIFORNIA BIOPROCESS VALIDATION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 31. FLORIDA BIOPROCESS VALIDATION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 32. ILLINOIS BIOPROCESS VALIDATION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 33. NEW YORK BIOPROCESS VALIDATION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 34. OHIO BIOPROCESS VALIDATION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 35. PENNSYLVANIA BIOPROCESS VALIDATION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 36. TEXAS BIOPROCESS VALIDATION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 37. UNITED STATES BIOPROCESS VALIDATION MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 38. UNITED STATES BIOPROCESS VALIDATION MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 39. UNITED STATES BIOPROCESS VALIDATION MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021
List of Tables
TABLE 1. UNITED STATES BIOPROCESS VALIDATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
TABLE 3. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 4. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY STATE, 2018-2027 (USD MILLION)
TABLE 5. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 6. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY COMPATIBILITY TESTING SERVICES, 2018-2027 (USD MILLION)
TABLE 7. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY COMPATIBILITY TESTING SERVICES, BY STATE, 2018-2027 (USD MILLION)
TABLE 8. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY EXTRACTABLES/LEACHABLES TESTING SERVICES, 2018-2027 (USD MILLION)
TABLE 9. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY EXTRACTABLES/LEACHABLES TESTING SERVICES, BY STATE, 2018-2027 (USD MILLION)
TABLE 10. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY INTEGRITY TESTING SERVICES, 2018-2027 (USD MILLION)
TABLE 11. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY INTEGRITY TESTING SERVICES, BY STATE, 2018-2027 (USD MILLION)
TABLE 12. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY MICROBIOLOGICAL TESTING SERVICES, 2018-2027 (USD MILLION)
TABLE 13. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY MICROBIOLOGICAL TESTING SERVICES, BY STATE, 2018-2027 (USD MILLION)
TABLE 14. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2027 (USD MILLION)
TABLE 15. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY BIOREACTORS, 2018-2027 (USD MILLION)
TABLE 16. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY BIOREACTORS, BY STATE, 2018-2027 (USD MILLION)
TABLE 17. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY FILTER ELEMENTS, 2018-2027 (USD MILLION)
TABLE 18. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY FILTER ELEMENTS, BY STATE, 2018-2027 (USD MILLION)
TABLE 19. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY FREEZING AND THAWING PROCESS BAGS, 2018-2027 (USD MILLION)
TABLE 20. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY FREEZING AND THAWING PROCESS BAGS, BY STATE, 2018-2027 (USD MILLION)
TABLE 21. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY MEDIA CONTAINERS AND BAGS, 2018-2027 (USD MILLION)
TABLE 22. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY MEDIA CONTAINERS AND BAGS, BY STATE, 2018-2027 (USD MILLION)
TABLE 23. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY MIXING SYSTEMS, 2018-2027 (USD MILLION)
TABLE 24. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY MIXING SYSTEMS, BY STATE, 2018-2027 (USD MILLION)
TABLE 25. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY TRANSFER SYSTEMS, 2018-2027 (USD MILLION)
TABLE 26. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY TRANSFER SYSTEMS, BY STATE, 2018-2027 (USD MILLION)
TABLE 27. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 28. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2027 (USD MILLION)
TABLE 29. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY STATE, 2018-2027 (USD MILLION)
TABLE 30. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, 2018-2027 (USD MILLION)
TABLE 31. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, BY STATE, 2018-2027 (USD MILLION)
TABLE 32. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2027 (USD MILLION)
TABLE 33. UNITED STATES BIOPROCESS VALIDATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY STATE, 2018-2027 (USD MILLION)
TABLE 34. CALIFORNIA BIOPROCESS VALIDATION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 35. CALIFORNIA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 36. CALIFORNIA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2027 (USD MILLION)
TABLE 37. CALIFORNIA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 38. FLORIDA BIOPROCESS VALIDATION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 39. FLORIDA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 40. FLORIDA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2027 (USD MILLION)
TABLE 41. FLORIDA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 42. ILLINOIS BIOPROCESS VALIDATION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 43. ILLINOIS BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 44. ILLINOIS BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2027 (USD MILLION)
TABLE 45. ILLINOIS BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 46. NEW YORK BIOPROCESS VALIDATION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 47. NEW YORK BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 48. NEW YORK BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2027 (USD MILLION)
TABLE 49. NEW YORK BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 50. OHIO BIOPROCESS VALIDATION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 51. OHIO BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 52. OHIO BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2027 (USD MILLION)
TABLE 53. OHIO BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 54. PENNSYLVANIA BIOPROCESS VALIDATION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 55. PENNSYLVANIA BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 56. PENNSYLVANIA BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2027 (USD MILLION)
TABLE 57. PENNSYLVANIA BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 58. TEXAS BIOPROCESS VALIDATION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 59. TEXAS BIOPROCESS VALIDATION MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 60. TEXAS BIOPROCESS VALIDATION MARKET SIZE, BY PROCESS COMPONENT, 2018-2027 (USD MILLION)
TABLE 61. TEXAS BIOPROCESS VALIDATION MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 62. UNITED STATES BIOPROCESS VALIDATION MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 63. UNITED STATES BIOPROCESS VALIDATION MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 64. UNITED STATES BIOPROCESS VALIDATION MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 65. UNITED STATES BIOPROCESS VALIDATION MARKET RANKING, BY KEY PLAYER, 2021
TABLE 66. UNITED STATES BIOPROCESS VALIDATION MARKET SHARE, BY KEY PLAYER, 2021
TABLE 67. UNITED STATES BIOPROCESS VALIDATION MARKET MERGER & ACQUISITION
TABLE 68. UNITED STATES BIOPROCESS VALIDATION MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 69. UNITED STATES BIOPROCESS VALIDATION MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 70. UNITED STATES BIOPROCESS VALIDATION MARKET INVESTMENT & FUNDING
TABLE 71. UNITED STATES BIOPROCESS VALIDATION MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 72. UNITED STATES BIOPROCESS VALIDATION MARKET: LICENSE & PRICING

Companies Mentioned

  • Almac Group
  • BiOZEEN
  • Cobetter Filtration Equipment Co., Ltd.
  • Doc S.r.l
  • Eurofins Scientific
  • Hangzhou Anow Microfiltration Co., Ltd.
  • Meissner Filtration Products, Inc.
  • Merck KGaA
  • Pall Corporation
  • Porvair plc
  • Sartorius Stedim Biotech S.A.
  • SGS S.A.
  • Thermo Fisher Scientific, Inc
  • Tianshan Precision Filter Material Co., Ltd.
  • Toxikon Corporation

Methodology

Loading
LOADING...